CLNN · NASDAQ
Clene (CLNN) Stock Price & Fundamentals
Clene (CLNN) closed at $846.74 on Oct 9, 2026, up 1.01% from the previous close of $838.30.
Share price, past year
1Y +19.81%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $846.74 |
| Sep 30, 2026 | $834.64 |
| Aug 31, 2026 | $869.62 |
| Jul 31, 2026 | $876.61 |
| Jun 30, 2026 | $819.32 |
| May 29, 2026 | $814.29 |
| Apr 30, 2026 | $800.98 |
| Mar 31, 2026 | $838.87 |
| Feb 27, 2026 | $785.36 |
| Jan 30, 2026 | $790.32 |
| Dec 31, 2025 | $767.96 |
| Nov 28, 2025 | $762.46 |
| Oct 31, 2025 | $715.79 |
Key statistics
- Market cap
- $10.82B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- $197.00K
- Net income (TTM)
- −$39.52M
- Shares outstanding
- 12.8M
- Dividend yield
- —
- 52-week range
- $690.69 – $884.30
Clene's market cap is $10.82B, based on a share price of $846.74 and 12.8M shares outstanding as of Jun 30, 2026.
Financials
Clene reported revenue of $200.00K for fiscal 2025, down 41.52% from fiscal 2024.
Clene reported a net loss of $26.17M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $200.00K | −41.5% | −$26.17M | −13,086.5% | — | −$18.59M |
| FY2024ended Dec 31, 2024 | $342.00K | −47.7% | −$39.40M | −11,520.5% | — | −$21.34M |
| FY2023ended Dec 31, 2023 | $654.00K | +38.3% | −$49.50M | −7,569.4% | — | −$30.50M |
| FY2022ended Dec 31, 2022 | $473.00K | −34.6% | −$29.92M | −6,325.2% | — | −$44.19M |
| FY2021ended Dec 31, 2021 | $723.00K | +251.0% | −$9.74M | −1,347.2% | −$0.16 | −$35.96M |
| FY2020ended Dec 31, 2020 | $206.00K | — | −$19.28M | −9,357.8% | −$1.10 | −$19.32M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $90.00K | −$13.42M | — |
| Q1 FY2026ended Mar 31, 2026 | $15.00K | −$8.09M | — |
| Q4 FY2025ended Dec 31, 2025 | $77.00K | −$9.23M | — |
| Q3 FY2025ended Sep 30, 2025 | $15.00K | −$8.78M | — |
| Q2 FY2025ended Jun 30, 2025 | $27.00K | −$7.42M | — |
| Q1 FY2025ended Mar 31, 2025 | $81.00K | −$751.00K | — |
| Q4 FY2024ended Dec 31, 2024 | $91.00K | −$13.55M | — |
| Q3 FY2024ended Sep 30, 2024 | $87.00K | −$7.99M | — |
Company profile
- Name
- Clene Inc.
- Ticker
- CLNN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 6550 South Millrock Drive, Suite G50, Salt Lake City, UT 84121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001822791
Recent SEC filings
- Sep 16, 2026
- Aug 14, 2026
- Aug 14, 2026
- Aug 10, 2026
- May 22, 2026
- May 14, 2026
- May 14, 2026
- May 5, 2026
Frequently asked questions
What is Clene's stock price?
Clene (CLNN) closed at $846.74 on Oct 9, 2026, up 1.01% from the previous close of $838.30.
What is Clene's market cap?
Clene's market cap is $10.82B, based on a share price of $846.74 and 12.8M shares outstanding as of Jun 30, 2026.
How much revenue does Clene make?
Clene reported revenue of $200.00K for fiscal 2025, down 41.52% from fiscal 2024.
Does Clene pay a dividend?
Clene's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Clene Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures